Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Abbott today announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

This growth was bolstered by the company’s strategic focus on the spinal cord injury rehabilitation market and its unique neuromodulation technology. Despite a net loss of €35.7 million ...

This growth was bolstered by the company’s strategic focus on the spinal cord injury rehabilitation market and its unique neuromodulation technology. Despite a net loss of €35.7 million, slightly ...